# Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

> **NCT05047926** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 90 (actual)

## Conditions studied

- Advanced Ovarian Carcinoma
- Stage IIIC Fallopian Tube Cancer AJCC v8
- Stage IIIC Ovarian Cancer AJCC v8
- Stage IIIC Primary Peritoneal Cancer AJCC v8
- Stage IV Fallopian Tube Cancer AJCC v8
- Stage IV Ovarian Cancer AJCC v8
- Stage IV Primary Peritoneal Cancer AJCC v8

## Interventions

- **BEHAVIORAL:** Behavioral Counseling
- **DIETARY_SUPPLEMENT:** Nutritional Supplement Drink
- **OTHER:** Physical Activity
- **OTHER:** Survey Administration
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Biospecimen Collection
- **BEHAVIORAL:** Health Education
- **OTHER:** Medical Device Usage and Evaluation

## Key facts

- **NCT ID:** NCT05047926
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-05
- **Primary completion:** 2025-07-08
- **Final completion:** 2025-07-08
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05047926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05047926, "Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT05047926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*